Scopus Integrated Directly into Editors’ and Reviewers’ Workflow
Amsterdam, March 28, 2006 – Elsevier announced today that all editors and reviewers using EES, Elsevier’s online submission and peer-review system will benefit from the integration of Scopus, the world’s largest abstract and citation database of research information and quality internet sources. Elsevier’s 7,000 editors now enjoy unlimited access to Scopus, while Elsevier's network of 200,000 reviewers receive a month’s access to further support them during the peer review process. Scopus’ user-friendly search bar is embedded directly in the EES system, enabling reviewers to instantly locate an author’s related articles and references as well as track citations.
Merv Fingas, head of the Emergencies Science Division at Canada’s Environmental Technology Center in Ottawa, Ontario and Editor of Journal of Hazardous Materials remarks, “Scopus is a great asset to my journal work. I use it all the time to find reviewers – in fact, I have stopped using my own database of reviewers as I find Scopus much more effective.”
Launched in 2003, EES is an online submission and peer-review system which enhances the journal publication process by providing a seamless end-to-end online workflow. Herman van Campenhout, CEO Science & Technology, Elsevier, adds “Since EES recently welcomed its thousandth journal to the system; we are pleased to report that the time needed for the complete editorial process – from submission to acceptance – has been reduced by almost 9 weeks. Adding Scopus underscores our ongoing commitment to our reviewers and editors with best-in-class publishing services.”
"EES and Scopus are a natural fit. Making Scopus accessible to our reviewers and editors is a significant step in Elsevier’s commitment to support the research community in the fundamentally important task of peer review" says Jaco Zijlstra, Director of Scopus.
# # #
Covering the world’s research literature, Scopus is the largest and easiest to use navigation tool ever built. Scopus is designed and developed with over 300 users and librarians internationally. Its unique database contains abstracts and references from over 14,000 titles from 4,000 different publishers, ensuring broad interdisciplinary coverage. In addition, Scopus not only offers users citation information about the articles covered, but also integrates web & patent searches directly from its clean and simple interface. Direct links to full-text articles, library resources and other applications like reference management software, make Scopus quicker, easier and more comprehensive to use than any other literature research tool. For more information about Scopus please visit www.info.scopus.com.
Notes to Editors:
Please contact Elsevier’s E-Submission Support department for detailed questions concerning the EES system.
US & Canada: +1 888 834 7287 (toll-free for US & Canadian customers)
Asia & Pacific: +81 3 5561 5032
Europe & ROW: +353 61 709 190
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.
Phone: +31 20 485 2025